Search

Author/Creator Barlow, William

2. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. Issue 10179 (6th April 2019)

Authors:
Gray, Richard; Bradley, Rosie; Braybrooke, Jeremy; Liu, Zulian; Peto, Richard; Davies, Lucy; Dodwell, David; McGale, Paul; Pan, Hongchao; Taylor, Carolyn; Barlow, William; Bliss, Judith; Bruzzi, Paolo; Cameron, David; Fountzilas, George; Loibl, Sibylle; Mackey, John; Martin, Miguel; Del Mastro, L...
Journal:
Lancet
Issue:
Volume 393:Issue 10179(2019)
Page Start:
1440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Issue 1 (January 2018)

Authors:
Asselain, Bernard; Barlow, William; Bartlett, John; Bergh, Jonas; Bergsten-Nordström, Elizabeth; Bliss, Judith; Boccardo, Francesco; Boddington, Clare; Bogaerts, Jan; Bonadonna, Gianni; Bradley, Rosie; Brain, Etienne; Braybrooke, Jeremy; Broet, Philippe; Bryant, John; Burrett, Julie; Cameron, Dav...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival. (2nd April 2020)

Authors:
Cannioto, Rikki A; Hutson, Alan; Dighe, Shruti; McCann, William; McCann, Susan E; Zirpoli, Gary R; Barlow, William; Kelly, Kara M; DeNysschen, Carol A; Hershman, Dawn L; Unger, Joseph M; Moore, Halle C F; Stewart, James A; Isaacs, Claudine; Hobday, Timothy J; Salim, Muhammad; Hortobagyi, Gabriel ...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 1(2021)
Page Start:
54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226). (3rd April 2023)

Authors:
Bergqvist, Mattias; Nordmark, Adrian; Williams, Amy; Paoletti, Costanza; Barlow, William; Cobain, Erin F.; Mehta, Rita S.; Gralow, Julie R.; Hortobagyi, Gabriel N.; Albain, Kathy S.; Pusztai, Lajos; Sharma, Priyanka; Godwin, Andrew K.; Thompson, Alastair M.; Hayes, Daniel F.; Rae, James M.
Journal:
Biomarkers
Issue:
Volume 28:Number 3(2023)
Page Start:
313
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗